The Discounted Cash Flow (DCF) valuation of Neogenomics Inc (NEO) is (13.57) USD. With the latest stock price at 10.05 USD, the upside of Neogenomics Inc based on DCF is -235.0%.
Based on the latest price of 10.05 USD and our DCF valuation, Neogenomics Inc (NEO) is a sell. selling NEO stocks now will result in a potential gain of 235.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 9.0% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (41.18) - (8.95) | (13.57) |
| Upside | -509.8% - -189.1% | -235.0% |